Britain COvid-19

An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS
Coronavirus chronicle

Britain approves Merck's oral Covid-19 pill

The Medicines and Healthcare products Regulatory Agency recommended that the drug be used as soon as possible following a positive Covid-19 test and within five days of the onset of symptoms.